High materiality8/10
Nurix Therapeutics price target raised to $33 from $30 at RBC Capital
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
NRIX price target updated by RBC Capital; target raised to $33 from $30.
- NRIX target raised to $33 from $30 at RBC Capital
Key facts
- 01
Target: $33
- 02
Posted price: $22.33
- 03
Analyst firm: RBC Capital
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.